Literature DB >> 28096464

Functional Transformation of C-reactive Protein by Hydrogen Peroxide.

Sanjay K Singh1, Avinash Thirumalai1, Asmita Pathak1, Donald N Ngwa1, Alok Agrawal2.   

Abstract

C-reactive protein (CRP) is present at sites of inflammation including amyloid plaques, atherosclerotic lesions, and arthritic joints. CRP, in its native pentameric structural conformation, binds to cells and molecules that have exposed phosphocholine (PCh) groups. CRP, in its non-native pentameric structural conformation, binds to a variety of deposited, denatured, and aggregated proteins, in addition to binding to PCh-containing substances. In this study, we investigated the effects of H2O2, a prototypical reactive oxygen species that is also present at sites of inflammation, on the ligand recognition function of CRP. Controlled H2O2 treatment of native CRP did not monomerize CRP and did not affect the PCh binding activity of CRP. In solid phase ELISA-based ligand binding assays, purified pentameric H2O2-treated CRP bound to a number of immobilized proteins including oxidized LDL, IgG, amyloid β peptide 1-42, C4b-binding protein, and factor H, in a CRP concentration- and ligand concentration-dependent manner. Using oxidized LDL as a representative protein ligand for H2O2-treated CRP, we found that the binding occurred in a Ca2+-independent manner and did not involve the PCh-binding site of CRP. We conclude that H2O2 is a biological modifier of the structure and ligand recognition function of CRP. Overall, the data suggest that the ligand recognition function of CRP is dependent on the presence of an inflammatory microenvironment. We hypothesize that one of the functions of CRP at sites of inflammation is to sense the inflammatory microenvironment, change its own structure in response but remain pentameric, and then bind to pathogenic proteins deposited at those sites.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  host defense; immunology; inflammation; innate immunity; ligand-binding protein

Mesh:

Substances:

Year:  2017        PMID: 28096464      PMCID: PMC5336149          DOI: 10.1074/jbc.M116.773176

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  84 in total

Review 1.  Redox regulation in the extracellular environment.

Authors:  Filomena G Ottaviano; Diane E Handy; Joseph Loscalzo
Journal:  Circ J       Date:  2008-01       Impact factor: 2.993

2.  Human L-ficolin recognizes phosphocholine moieties of pneumococcal teichoic acid.

Authors:  Emilie Vassal-Stermann; Monique Lacroix; Evelyne Gout; Emmanuelle Laffly; Christian M Pedersen; Lydie Martin; Ana Amoroso; Richard R Schmidt; Ulrich Zähringer; Christine Gaboriaud; Anne-Marie Di Guilmi; Nicole M Thielens
Journal:  J Immunol       Date:  2014-10-24       Impact factor: 5.422

3.  Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3).

Authors:  Gunda Millonig; Ingo Ganzleben; Teresa Peccerella; Guillem Casanovas; Lidia Brodziak-Jarosz; Katja Breitkopf-Heinlein; Tobias P Dick; Helmut-Karl Seitz; Martina U Muckenthaler; Sebastian Mueller
Journal:  J Biol Chem       Date:  2012-08-29       Impact factor: 5.157

4.  C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance.

Authors:  Huijun Sun; Tomonari Koike; Tomonaga Ichikawa; Kinta Hatakeyama; Masashi Shiomi; Bo Zhang; Shuji Kitajima; Masatoshi Morimoto; Teruo Watanabe; Yujiro Asada; Yuqing E Chen; Jianglin Fan
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

5.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.

Authors:  Mi-Kyung Chang; Christoph J Binder; Michael Torzewski; Joseph L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

6.  Complement factor H binds to denatured rather than to native pentameric C-reactive protein.

Authors:  Svetlana Hakobyan; Claire L Harris; Carmen W van den Berg; Maria Carmen Fernandez-Alonso; Elena Goicoechea de Jorge; Santiago Rodriguez de Cordoba; German Rivas; Palma Mangione; Mark B Pepys; B Paul Morgan
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

7.  Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia.

Authors:  Alexander Kovacs; Per Tornvall; Roland Nilsson; Jesper Tegnér; Anders Hamsten; Johan Björkegren
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-16       Impact factor: 11.205

8.  Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.

Authors:  Steffen U Eisenhardt; Jonathon Habersberger; Andrew Murphy; Yung-Chih Chen; Kevin J Woollard; Nicole Bassler; Hongwei Qian; Constantin von Zur Muhlen; Christoph E Hagemeyer; Ingo Ahrens; Jaye Chin-Dusting; Alex Bobik; Karlheinz Peter
Journal:  Circ Res       Date:  2009-06-11       Impact factor: 17.367

9.  Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation.

Authors:  Ádám I Csincsi; Anne Kopp; Miklós Zöldi; Zsófia Bánlaki; Barbara Uzonyi; Mario Hebecker; Joseph J E Caesar; Matthew C Pickering; Kenji Daigo; Takao Hamakubo; Susan M Lea; Elena Goicoechea de Jorge; Mihály Józsi
Journal:  J Immunol       Date:  2015-04-08       Impact factor: 5.422

10.  Effect of CRP on Some of the in vitro Physicochemical Properties of LDL.

Authors:  Hashem Nayeri; Gholam Ali Naderi; Masoud Saleh Moghadam; Samaneh Mohamadzadeh; Maryam Boshtam; Narges Jafari Dinani; Adel Abedpour Dehkordi
Journal:  ARYA Atheroscler       Date:  2010
View more
  13 in total

Review 1.  Redox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes.

Authors:  Ashley R Burg; Hubert M Tse
Journal:  Antioxid Redox Signal       Date:  2017-11-27       Impact factor: 8.401

2.  Structurally Altered, Not Wild-Type, Pentameric C-Reactive Protein Inhibits Formation of Amyloid-β Fibrils.

Authors:  Donald N Ngwa; Alok Agrawal
Journal:  J Immunol       Date:  2022-08-17       Impact factor: 5.426

Review 3.  Evolution of C-Reactive Protein.

Authors:  Asmita Pathak; Alok Agrawal
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

Review 4.  Structure-Function Relationships of C-Reactive Protein in Bacterial Infection.

Authors:  Donald N Ngwa; Alok Agrawal
Journal:  Front Immunol       Date:  2019-02-26       Impact factor: 7.561

5.  Zinc-α2-glycoprotein as an inhibitor of amine oxidase copper-containing 3.

Authors:  Matthias Romauch
Journal:  Open Biol       Date:  2020-04-22       Impact factor: 6.411

Review 6.  The Multiple Faces of C-Reactive Protein-Physiological and Pathophysiological Implications in Cardiovascular Disease.

Authors:  Magdalena Boncler; Yi Wu; Cezary Watala
Journal:  Molecules       Date:  2019-05-30       Impact factor: 4.927

Review 7.  C-Reactive Protein in Atherothrombosis and Angiogenesis.

Authors:  Lina Badimon; Esther Peña; Gemma Arderiu; Teresa Padró; Mark Slevin; Gemma Vilahur; Gemma Chiva-Blanch
Journal:  Front Immunol       Date:  2018-03-02       Impact factor: 7.561

Review 8.  C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration.

Authors:  Blanca Molins; Sara Romero-Vázquez; Pablo Fuentes-Prior; Alfredo Adan; Andrew D Dick
Journal:  Front Immunol       Date:  2018-04-19       Impact factor: 7.561

Review 9.  Functionality of C-Reactive Protein for Atheroprotection.

Authors:  Sanjay K Singh; Alok Agrawal
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561

10.  Conformationally Altered C-Reactive Protein Capable of Binding to Atherogenic Lipoproteins Reduces Atherosclerosis.

Authors:  Asmita Pathak; Sanjay K Singh; Douglas P Thewke; Alok Agrawal
Journal:  Front Immunol       Date:  2020-08-11       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.